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Introduction
The Eph receptor tyrosine kinases and their membrane-bound
ligands, the ephrins, are key regulators of cell organization
(Holder and Klein, 1999). During development, Eph and
their ephrin ligands are expressed at the limit of cellular
compartments (Flenniken et al., 1996; Gale et al., 1996; Wang
et al., 1998). Their interaction generates bidirectional signaling
that is proposed to limit cell migration through embryonic
boundaries (Mellitzer et al., 1999). Various studies on
Eph/ephrin function during embryonic development suggest
that Eph receptors and ephrins act through modulation of cell
adhesion and motility (Bruckner and Klein, 1998; Xu et al.,
2000). Both receptor- and ligand-mediated signaling can
modulate adhesion, spreading or migration of various cell
types, and accumulating evidence suggests that this effect is
mediated through modulations of integrin function (Davy et al.,
1999; Davy and Robbins, 2000; Huynh-Do et al., 1999; Miao
et al., 2000). Upon activation, signaling molecules implicated
in cytoskeletal organization are recruited to both Eph and
ephrin, supporting the concept of direct communication with
the intracellular machinery driving cytoskeletal plasticity
(Mellitzer et al., 2000). The small GTPases of the Rho family
are key intermediates in cellular signaling that originates from
clustered cell adhesion receptors and elicit distinct effects on
the actin cytoskeleton (Hall, 1998). They have been implicated
in some biological effects of ephrins in neuronal cells (Shamah
et al., 2001; Wahl et al., 2000), and a recent report suggests
that EphA3 activation by ephrinA5 in melanoma cells induces
de-adhesion through the activation of RhoA (Lawrenson et al.,
2002).
While integrin activation is required in various biological
processes, such as cell-cycle progression, growth and cell
survival, a dynamic in the adhesion process is associated with
either physiological or pathological situations. Decreased
adhesion is important in the destabilization of blood vessel
structures during angiogenesis (Yancopoulos et al., 2000).
EphrinA1 and its cognate receptor, EphA2, are strongly
expressed at sites of neovascularization, and vascular
endothelial growth factor (VEGF), one of the most-potent
angiogenic factors, induces the expression of ephrinA1 in
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Interactions between the Eph receptor tyrosine kinase and
ephrin ligands transduce short-range signals regulating
axon pathfinding, development of the cardiovascular
system, as well as migration and spreading of neuronal and
non-neuronal cells. Some of these effects are believed to be
mediated by alterations in actin dynamics. The members
of the small Rho GTPase family elicit various effects on
actin structures and are probably involved in Eph receptor-
induced actin modulation. EphrinA1 is proposed to
contribute to angiogenesis as it is strongly expressed at sites
of neovascularization. Moreover, angiogenic factors induce
the expression of ephrinA1 in endothelial cells. In this
study, using rat vascular smooth muscle cells (VSMCs), we
investigated the contribution of the small Rho GTPases in
ephrinA1-induced integrin inactivation. EphrinA1 did not
significantly affect early adhesion of VSMCs on purified
laminin or fibronectin, but strongly impaired cell
spreading. The Rho kinase inhibitor Y-27632 partly
reversed the ephrinA1 effect, suggesting involvement of
Rho in this model. However, inhibition of RhoA synthesis
with short interfering (si)RNA had a modest effect,
suggesting that RhoA plays a limited role in ephrinA1-
mediated inhibition of spreading in VSMCs. The ephrinA1-
mediated morphological alterations correlated with
inhibition of Rac1 and p21-activated kinase 1 (PAK1)
activity, and were antagonized by the expression of a
constitutively active Rac mutant. Moreover, repression of
Rac1 synthesis with siRNA amplifies the ephrinA1-induced
inhibition of spreading. Finally, sphingosine-1-phosphate
(S1P), a lipid mediator known to inhibit Rac activation in
VSMCs amplifies the ephrinA1 effect. In conclusion, our
results emphasize the role of the Rac/PAK pathway in
ephrinA1-mediated inhibition of spreading. In this way,
ephrinA1, alone or in synergy with S1P, can participate in
blood vessel destabilization, a prerequisite for angiogenesis.
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endothelial cells (Cheng et al., 2002; Ogawa et al., 2000).
Therefore, it is possible that the pro-angiogenic effects of
Eph/ephrin are mediated not only through local modulation of
cell adhesion and motility of endothelial cells but also of
perivascular cells. To test this hypothesis, we analyzed the
impact of EphA activation by ephrinA1 on VSMC adhesion
and morphology.
Investigation of the signaling pathways involved in
ephrinA1-induced morphological alterations, in particular
spreading inhibition, underlined the key role played by the
Rac/PAK pathway. While specific ablation of RhoA using the
double-stranded siRNA approach had a limited effect,
decreased levels of Rac1 using siRNA or decreased activation
of Rac1 using S1P led to a decrease in cell spreading and
amplification of the action of ephrinA1. We therefore conclude
that the Rac activity in VSMCs is essential in mediating the
action of ephrinA1, a control point that could be reinforced in
vivo by the lipid mediator S1P (Ryu et al., 2002).
Materials and Methods
Reagents and cells
EphrinA1/Fc was produced as described (Miao et al., 2000).
EphrinB1/Fc and EphB2/Fc were purchased from R&D Systems.
Antibodies and reagents were purchased from the following
manufacturers: mouse anti-phosphotyrosine PY99, mouse anti-RhoA
(26C4) and rabbit anti-EphA2 antibodies were from Santa Cruz
Biotechnology; mouse anti-Rac1 was from Upstate Biotechnology;
mouse anti-Cdc42 was from Transduction Laboratories; rabbit anti-
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Fig. 1. EphrinA1 represses spreading
of VSMCs on laminin.
(A) Activation of EphA2 by
immobilized ephrinA1. Quiescent
VSMCs plated on tissue culture
dishes coated with laminin (0.25
m g/cm2) and 1 m g/cm2 of either Fc or
ephrinA1 for the indicated times
were lysed as described. EphA2 was
precipitated (IP) with an anti-EphA2
antibody. Immunoblotting was
performed using an anti-
phosphotyrosine to determine the
activation of EphA2 (Phospho-
EphA2) or an anti-EphA2 to control
loading. The fold induction is
calculated from densitometric
measurements of phosphotyrosine
signal normalized to EphA2 loading
in lysates of ephrinA1-stimulated
cells compared with Fc control at
each time point. (B) Representative
phase-contrast microscopy of
quiescent VSMCs allowed to spread
for 16 hours on tissue culture dishes
coated with laminin (0.25 m g/cm2)
and the indicated amounts of control
Fc fragment (L+Fc) or ephrinA1/Fc
(L+A1). Reversion of the effect was
initiated by trypsinizing VSMCs
attached on dishes coated with
laminin and 1 m g/cm2 of either Fc or
A1, seeding them on another dish
coated with laminin alone and
allowing spreading for 24 hours. Bar,
40 m m. (C) Quiescent VSMCs were
allowed to spread for the indicated
times on tissue culture dishes coated
with laminin (0.25 m g/cm2) and 1
m g/cm2 of either Fc (L+Fc) or
ephrinA1/Fc (L+A1). Bar, 40 m m.
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GFP was from Clontech and protein-A-Sepharose was from
Amersham Pharmacia Biotech. Rabbit anti-p42MAPKinase (E1B4)
was developed in our laboratory (Le Gall et al., 1998) and rabbit
anti-phospho-PAK1 antibody was a kind gift of M. E. Greenberg
(Children’s Hospital, Harvard Medical School, Boston, MA). Cell
dissociation solution (CDS), phalloidin-TRITC, fibronectin, laminin
and S1P were from Sigma. The Fc fragment of human IgG was from
Jackson ImmunoResearch. VSMCs were isolated from rat thoracic
aortas by enzymatic digestion (Richard et al., 2000). VSMCs were
cultured in DMEM supplemented with 8% FCS, non-essential
amino acids, penicillin (50 U/ml) and streptomycin (50 m g/ml).
1G11 endothelial cells were cultured as previously described
(Vinals and Pouyssegur, 1999). Cells were starved by total
deprivation of serum for 16-20 hours.
Cell adhesion assay
To analyze cell adhesion and spreading on immobilized proteins,
tissue culture dishes were coated overnight with laminin (0.25
m g/cm2) and Fc (1 m g/cm2), or with laminin (0.25 m g/cm2) and
ephrin A1/Fc (1 m g/cm2) in PBS. In some experiments, laminin
was replaced by fibronectin (0.125 m g/cm2). Nonspecific sites were
blocked with 1% BSA for 30 minutes. Starved VSMCs were
detached non-enzymatically with CDS, washed twice in
DMEM+0.1% BSA and seeded on coated dishes in the same
medium. As already published by others, we observed that coating
with only ephrin A1/Fc only permits cell adhesion but does not
allow cell spreading.
Immunoprecipitation and immunoblotting
Subconfluent VSMCs were chilled on ice, rinsed twice with ice-
cold PBS and lysed in buffer containing 1% Triton X-100, 50mM
Tris pH 7.4, 100 mM NaCl, 50 mM NaF, 40 mM b -
glycerophosphate, 1 mM Na3VO4, 0.1 mM AEBSF, 4 m g/ml
aprotinin, 1 m g/ml leupeptin and 1 m g/ml pepstatin.
Immunoprecipitations were carried out using 1 m g of rabbit anti-
EphA2. After 1 hour of incubation at 4°C, 40 m l of protein-A-
Sepharose beads were added for 1 hour to capture immune
complexes. Beads were washed four times with lysis buffer and
boiled in 60 m l SDS-PAGE lysis buffer. For immunoblotting,
samples were separated on a 6% gel and transferred to Immobilon-
P PVDF membrane. EphA2 and phosphotyrosines were
immunodetected with the corresponding antibodies. The bands
were visualized with the electrochemiluminescence (ECL) system.
siRNA transfection
21-nucleotide RNAs were chemically synthesized and purified by
reverse-phase HPLC (Eurogentec). To inhibit Rac1 synthesis,
we used the 5 ¢ -GUUCUUAAUUUGCUUUUCCTT-3 ¢ and 5¢ -
GGAAAAGCAAAUUAAGAAC-3¢ oligoribonucleotides and, to
inhibit RhoA, we used the 5 ¢ -GAAGUCAAGCAUUU-
CUGUCTT-3¢ and 5¢ -GACAGAAAUGCUUGACUUCTT-3¢
oligoribonucleotides. Control siRNA primers corresponded to 21-
nucleotide RNAs from Drosophilia hypoxia inducible factor 1a .
Each pair of oligoribonucleotides was annealed at a concentration
of 20 m M in 100 mM potassium acetate, 2 mM magnesium acetate,
30 mM HEPES-KOH pH 7.4. Calcium phosphate-mediated
transfection was performed in 6-well plates with a final
concentration of 20 nM of siRNA. VSMCs were used in the
adhesion assay 48 hours post-transfection.
GTPase assay
After seeding on coated dishes, VSMCs suspended in
DMEM+0.1% BSA were harvested every 30 minutes, until 2
hours. Cells were chilled on ice and lysed in ice-cold buffer containing
1% Triton X-100, 25 mM HEPES pH 7.3, 150 mM NaCl, 4% glycerol,
0.1 mM AEBSF, 4 m g/ml aprotinin, 1 m g/ml leupeptin and 1 m g/ml
pepstatin. Lysates were centrifuged for 8 minutes at 13,000 g.
Supernatants were immediately frozen in liquid nitrogen and stored
at –80° until further use. An aliquot of each supernatant was denatured
in SDS-PAGE lysis buffer before freezing to measure the total
rhoGTPase content. For pull-down assays, supernatants were
incubated with 30 m g of GST-PBD protein (containing the Cdc42- and
Fig. 2. ROCK inhibitor Y27632 antagonizes the ephrinA1-mediated
repression of VSMC spreading whereas ephrinA1 does not modulate
RhoA activity. (A) Representative phase-contrast microscopy of quiescent
VSMCs allowed to spread on tissue culture dishes coated with laminin
(0.25 m g/cm2) and 1 m g/cm2 of either Fc (L+Fc) or ephrinA1/Fc (L+A1),
in the presence of 7 m M Y27632 or vehicle alone. Bar, 20 m m.
(B) Quiescent VSMCs were seeded on tissue culture dishes coated with
laminin and either Fc or ephrinA1/Fc (A1). Cells were harvested at the
indicated times and processed for pull-down experiments. RhoA activity
is determined by the amount of GST-RBD-bound RhoA (RhoA-GTP)
normalized to total RhoA in whole cell lysates. (C) Quiescent VSMCs
were stimulated (FCS) or not (C) with 10% FCS. After 5 minutes, cells
were harvested and processed for pull-down experiments. RhoA activity
is determined as described above (B).
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Rac-binding region of PAK-1B) or GST-RBD protein (containing the
Rho-binding region of rhotekin) affinity linked to glutathione
Sepharose beads for 30 minutes (Ren et al., 1999; Sander et al., 1999).
The beads were washed four times in lysis buffer and boiled in 60 m l
SDS-PAGE lysis buffer.
Retroviral infection
Retroviral supernatants were generated by transient transfection of
Phoenix cells with pBabeGFPRacN17 or pBabeGFPRacV12 and
were used to infect VSMCs. Two days post-infection, VSMCs were
starved and tested on tissue-culture-coated dishes.
Immunofluorescence labeling
VSMCs cultured for 4 hours on tissue-culture-coated dishes were
fixed with 3% paraformaldehyde in PBS for 20 minutes and
permeabilized with 0.2% Triton X-100 in PBS for 2 minutes. The
dishes were blocked with 1% BSA in PBS for 30 minutes and
incubated with phalloidin-TRITC (60 ng/ml) for 30 minutes.
Fluorescence was analyzed with a Leica DM-R microscope equipped
with a DC-200 digital camera.
Results
Inhibition of integrin-mediated cell spreading by
ephrinA1/Fc
Coated ephrinA1/Fc induced a sustained phosphorylation of
the EphA2 receptor in VSMCs, suggesting that it was able to
activate, in this model, an intracellular signaling cascade
(Fig. 1A). We next investigated the molecular mechanisms
controlling ephrinA1 activity by analyzing its impact on cell
attachment and spreading on tissue culture dishes coated with
purified components of extracellular matrix (ECM). VSMCs
were cultivated in dishes coated with purified ECM
components (laminin or fibronectin) and either the Fc fragment
of human IgG or recombinant ephrinA1/Fc. As observed by
phase-contrast microscopy, spreading of VSMCs on laminin
progressively decreased as the ephrinA1/Fc coating
concentration increased whereas the control Fc fragment, used
at the same concentrations, did not modulate the VSMC
morphology (Fig. 1B). In the presence of the highest
concentration of ephrinA1/Fc (1 m g/ml), the cells were not in
the process of dying as they were able, after detachment, to re-
spread as efficiently as control cells on a laminin coat (Fig. 1B,
right panels). The observed smaller size of the VSMCs first
attached to ephrinA1/Fc for 16 hours could be due to the
widely documented repression of protein synthesis, and
namely of cytoskeletal proteins, in non- or scarcely spread cells
(Deroanne et al., 1996; Lambert et al., 1992; Mooney et al.,
1994). A similar effect of ephrinA1/Fc was also observed with
endothelial cells (1G11) (not shown). The same inhibition
of laminin-mediated cell spreading was observed with
ephrinB1/Fc used at the same concentrations, while EphB2/Fc
had no effect (not shown). EphrinA1/Fc did not significantly
alter early adhesion to laminin as nearly all the cells adhere to
the coated dishes within 30 minutes in both tested conditions,
but strongly impair VSMC spreading (Fig. 1C). This effect was
already visible shortly after seeding the VSMCs. On control
dishes, 30 minutes after seeding, all the cells attached and
started to spread. Cell spreading gradually increased to reach
a maximum 2 hours thereafter. Cells attached as efficiently to
ephrinA1/Fc coated dishes as to control dishes, but were unable
to form lamellipodia and instead projected structures that are
likely to be buds of the lamellipodia. The length of these
structures reached a maximum 2 hours after seeding, to
progressively retract and disappear within 4 hours (Fig. 1C).
Replacement of laminin by fibronectin in this cellular model
gave the same results (not shown), suggesting that it was not
restricted to a specific ECM component and/or integrin.
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Fig. 3. Effect of RhoA silencing on cell spreading. (A) An siRNA targeting RhoA strongly reduced the RhoA protein level without a significant
effect on Rac1 and Cdc42 protein levels. Western blot analysis of whole cell lysates of VSMCs transfected with 20 nM of a control siRNA
(Control) or an siRNA targeting RhoA or left untransfected (C). 48 hours post-transfection, cells were lysed in SDS-PAGE loading buffer and
analyzed by immunoblotting with specific antibodies to RhoA, Rac1, Cdc42 and p42 MAP kinase. (B) Inhibition of RhoA with an siRNA
stabilizes process formation. Representative phase-contrast microscopy of quiescent VSMCs allowed to spread for 4 hours (a-d) on tissue
culture dishes coated with laminin and either Fc (a,b) or A1 (c,d). VSMCs transfected with control siRNA (a,c) or an siRNA targeting RhoA
(b,d) were used 48 hours post-transfection. Bar, 20 m m.
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Implication of the small GTPase RhoA
It was reported that some biological effects of
ephrinA5, a member of the ephrin family, are
mediated through the Rho-Rho kinase pathway (Wahl
et al., 2000). We therefore wanted to determine if such
pathways are implicated in ephrinA1-induced integrin
inactivation. First, VSMCs were cultured in the
absence or presence of the Rho kinase (ROCK)
inhibitor Y-27632. As seen in Fig. 2A, the cells
attached and spread as efficiently with or without Y-
27632 under control conditions. By contrast, the
ROCK inhibitor partially reversed the ephrinA1/Fc
effect on VSMC spreading, suggesting the
involvement of the Rho-ROCK pathway. Similar
results were obtained when laminin was replaced by
fibronectin (not shown). However, we did not observe
any activation of RhoA by ephrinA1/Fc (Fig. 2B),
whereas our pull-down assay revealed a strong
increase in RhoA activation with 10% FCS (Fig. 2C).
In an attempt to define further the implication of Rho
in our model, we tried to transfect by various means
an expression vector for RhoN19, a dominant-inactive
form of Rho, carrying a GFP-tag, but its expression
was nearly undetectable in our VSMCs (not shown).
Hence, we used siRNA (Elbashir et al., 2001) to ablate
specifically RhoA in VSMCs. As seen in Fig. 3, a 90%
reduction in the RhoA protein level was observed
48 hours post-transfection, without significant
modulation of the Rac1, Cdc42 and p42MAPK levels.
These cells were seeded on dishes coated with laminin
and either control Fc or ephrinA1/Fc. Interestingly,
repression of RhoA synthesis markedly increases the
length of processes (Fig. 3B). However, a lack of
RhoA expression does not reverse the effect of
Fig. 4. EphrinA1 inhibits the activation of Rac1 but does
not affect the activation of Cdc42. (A) Quiescent VSMCs
were seeded on tissue culture dishes coated with laminin
and either Fc or ephrinA1/Fc (A1). Cells were harvested at
the indicated times and processed for pull-down
experiments. Rac1 activity is determined by the amount of
GST-PBD-bound Rac1 (Rac1-GTP) normalized to total
Rac1 in whole cell lysates. (B) Densitometric analysis of
(A). Results are the mean±s.d. of three independent
experiments. (C) Quiescent VSMCs were seeded on tissue
culture dishes coated with laminin and either Fc or
ephrinA1/Fc (A1). Cells were harvested at the indicated
times and processed for pull-down experiments. Cdc42
activity is determined by the amount of GST-PBD-bound
Cdc42 (Cdc42-GTP) normalized to total Cdc42 in whole
cell lysates.
Fig. 5. EphrinA1 inhibits the activation of PAK1, an
effector of Rac1 signaling. (A) Quiescent VSMCs were
seeded on tissue culture dishes coated with laminin and
either Fc or ephrinA1/Fc (A1). Cells were lysed in SDS-
PAGE loading buffer at the indicated times. PAK1 activity
is indicated by the amount of phosphorylated PAK1
(phosphoPAK1) normalized to the total PAK1 in each cell
lysate. (B) Densitometric analysis of (A). Results are the
mean±s.d. of three independent experiments.
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ephrinA1 on cell spreading. These results suggest that RhoA
has a limited involvement in this cellular model.
Implication of the Rac and Cdc42 pathways
The morphological effects of ephrinA1/Fc, mainly
characterized by a lack of lamellipodia formation and a
transient extension of processes (Fig. 1C), suggested an
impairment of Rac1 and/or an increase in Cdc42 signaling
(Hall, 1998). Hence, we measured the activation level of these
small RhoGTPases with a pull-down assay. VSMCs were
harvested every 30 minutes until 120 minutes after seeding. In
control dishes, the level of activated Rac1 increased
progressively to reach a maximum 90 minutes after seeding
before returning to basal level. By contrast, ephrinA1
prevented this Rac1 activation mediated
by either spreading on laminin (Fig. 4A)
or fibronectin (not shown). As shown in
Fig. 4C, we were unable to detect any
significant modulation of Cdc42 activity
by ephrin A1/Fc even though we were
able to detect strong activation of Cdc42
in VSMCs stimulated with bradykinin
(not shown). However, it is interesting to
note that a basal activation of Cdc42 is
detected in all tested conditions.
To evaluate further the changes in the
Rac1 signaling pathway, we measured the
activation level of PAK1, the immediate
effector of Rac1, with an anti-phospho-
PAK1 antibody. As shown in Fig. 5,
ephrinA1/Fc strongly impaired the
phosphorylation of PAK1, suggesting that
EphA activation represses VSMC
spreading through inhibition of the
Rac/PAK pathway. To evaluate the
importance of the inactivation of this
pathway, VSMCs were infected with
retroviral vectors encoding the GFP-tagged
constitutive active and inactive forms of
Rac, respectively RacV12 and RacN17.
The constitutive activity of RacV12 was assessed in the pull-
down assay used previously (not shown). 48 hours post-
infection, the cells were used in the adhesion assay. More than
95% of infected or non-infected cells spread on a control coat.
As seen in Fig. 6A, VSMCs expressing RacV12 or RacN17
spread as efficiently as non-infected cells on tissue culture dishes
coated with laminin and control Fc. On tissue culture dishes
coated with laminin and ephrinA1/Fc, 65% of the RacV12-
expressing cells spread, whereas most of the RacN17-expressing
cells and non-infected cells were unable to spread (Fig. 6B,C).
S1P or a decreased level of Rac (via siRNA) amplify the
action of ephrinA1/Fc
To analyze further the involvement of Rac1 in the ephrinA1
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Fig. 6. Constitutively active Rac antagonizes
the ephrinA1-mediated repression of VSMC
spreading. (A-B) VSMCs expressing either
GFPRacN17 or GFPRacV12 cultured on
tissue culture dishes coated with laminin and
either Fc (A) or ephrinA1/Fc (B) were fixed 4
hours after seeding in the adhesion assay and
analyzed by immunofluorescence labeling
with DAPI and phalloidin-TRITC. Bar,
20 m m. (C) The morphology of GFPRacN17
(RacN17)- and GFPRacV12 (RacV12)-
expressing cells cultured on tissue culture
dishes coated with laminin and ephrinA1/Fc
from ten randomly chosen fields were scored
(spread or retracted). Data represent the
mean±s.d. of three independent experiments.
Non-infected cells (N.I.) in the same fields
were also scored and used as a control for the
ephrinA1 activity.
1373EphrinA1 inactivates integrins through rac
signaling pathway, we took advantage of interfering RNA
technology. An siRNA targeting Rac1 specifically was
designed and transfected into VSMCs. 48 hours post-
transfection, a 60-70% decrease in the Rac1 protein level was
observed, without significant modulation of the RhoA and
Cdc42 levels, in VSMCs (Fig. 7A). The siRNA of RhoA was
used as a positive control (Fig. 7A, lane 3). These cells were
tested in the adhesion assay in the presence of a suboptimal
concentration of ephrinA1/Fc. As illustrated in Fig. 7B and 7C,
the repression of Rac1 synthesis significantly enhanced
ephrinA1-mediated inhibition of spreading, further supporting
the involvement of Rac1 in this phenomenon.
S1P is a lipid mediator exerting various effects on
cytoskeletal organization depending on the cell type. In
VSMCs, S1P is known to inhibit Rac and to increase Rho
activity (Ryu et al., 2002). 0.5 m M S1P did not modulate the
ability of VSMCs to spread on a control tissue culture dish
coated with laminin and Fc (Fig. 8a,e). However, S1P
significantly reduced the spreading of VSMCs with a
suboptimal concentration of ephrinA1/Fc whereas, in the
presence of the highest concentration of ephrinA1/Fc, all the
cells were round (Fig. 8, compare b-d with f-h). These
observations suggest that S1P could amplify the effect of
ephrinA1/Fc on VSMCs through modulation of Rac, and
perhaps Rho, activity.
Discussion
Interaction between Eph receptor tyrosine kinase and ephrin
ligands transduce short-range signals regulating axon
pathfinding, development of the cardiovascular system, and
migration and spreading of neuronal and non-neuronal cells
(Boyd and Lackmann, 2001; Cheng et al., 2002; Knoll and
Drescher, 2002). Several Eph receptors and ephrins are
overexpressed in tumors especially during the more invasive
stages of tumor progression (Dodelet and Pasquale, 2000).
They are proposed to contribute to tumor progression by
modulating the adhesive properties of the cells (Lawrenson et
al., 2002). EphrinA1 and EphA2 are expressed in the tumor
vasculature and could contribute to the permanent remodeling
of these vessels (Ogawa et al., 2000). EphrinA1 was reported
to contribute to angiogenesis in vitro as well as in in vivo
models, and its expression is induced by several cytokines,
especially angiogenic factors such as VEGF, in endothelial
cells (Cheng et al., 2002; Daniel et al., 1996; Myers et al.,
2000; Pandey et al., 1995; Stein et al., 1998). We hypothesize
that one function of ephrinA1 expressed in endothelial cells is
to initiate a repulsive movement that will contribute to the
destabilization of blood vessels, a prerequisite for angiogenesis
(Yancopoulos et al., 2000). This concept encouraged us to
investigate the effect of ephrinA1 on VSMC adhesive
properties. It was reported that EphA activation inhibits
Fig. 7. Repression of Rac1 synthesis amplifies the ephrinA1-
mediated inhibition of VSMC spreading. (A) Western blot
analysis of whole cell lysates of VSMCs transfected with
calcium phosphate alone (Control), with an siRNA targeting
Rac1 (Rac1) or with an siRNA targeting RhoA (RhoA). 48
hours post-transfection, cells were lysed in SDS-PAGE
loading buffer and analyzed by immunoblotting with specific
antibodies to RhoA, Rac1, Cdc42 and p42 MAP kinase.
(B) Representative phase-contrast microscopy of quiescent
VSMCs cultured for 4 hours on tissue culture dishes coated
with laminin (0.25 m g/cm2) and 0.5 m g of either Fc
(L+0.5Fc) or ephrinA1/Fc (L+0.5A1). VSMCs were
transfected with calcium phosphate alone (Control), with
20 nM siRNA Rac1 (Rac1) or 20 nM siRNA RhoA (RhoA).
Bar, 20 m m. (C) The morphology of control (Control), siRNA Rac1 (Rac1) or siRNA RhoA (RhoA)-treated cells from eight randomly chosen
fields were scored (spread or retracted). Data represent the mean±s.d. of three independent experiments.
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integrin function in PC-3 epithelial cells through SHP2-
dependent FAK inactivation (Miao et al., 2000). However, this
phosphatase was also reported to control the activation level of
RhoA (Schoenwaelder et al., 2000). Some biological effects of
the ephrins are dependent on RhoGTPases (Wahl et al., 2000).
Recently, it was reported that EphA is constitutively associated
with a novel RhoGTPase exchange factor, named ephexin
(Shamah et al., 2001). Finally, a recent report suggested that
de-adhesion of EphA3-expressing melanoma cells by
ephrinA5 is mediated through a Rho and crkII-dependent
pathway (Lawrenson et al., 2002).
In the present study, we have shown that the morphological
effects of EphA activation in VSMCs are associated with
inhibition of the Rac/PAK pathway and can be rescued by
constitutive activation of Rac. Moreover, repression of Rac1
synthesis by means of an siRNA strategy amplifies the
ephrinA1-mediated spreading inhibition, further supporting the
key role played by Rac1 in this process. These observations are
in agreement with the lack of lamellipodia formation in the
presence of ephrinA1/Fc as the establishment of this cell
structure is dependent on Rac activity (Hall, 1998). In this way,
ephrins can compete with integrin-mediated signaling,
but could also interfere with the optimal localization of
activated integrins, which is mediated in some cases by
activated Rac (Kiosses et al., 2001). EphrinA1 can
also mediate its effect partly through decreased
phosphorylation of the myosin light chain (C.D. and
J.P., unpublished), a protein activated by PAK1 (Sells
et al., 1999). This molecule is localized to lamellipodia
and proposed to contribute to membrane extensions at
the leading edge (Sells et al., 1999; Sells et al., 2000).
Cdc42 is also able to activate PAK1. However, this
GTPase is probably not involved in the morphological
effect of ephrinA1 as we did not observe any
modulation of its activity by ephrinA1/Fc, whereas our
pull-down assay allowed the detection of a strong
increase of Cdc42 activity by bradykinin treatment. As
recently reported by Carter et al. (Carter et al., 2002),
spreading of NIH3T3 on ephrinA1/Fc was also
observed in our culture model while VSMCs only bind
to immobilized ephrinA1/Fc and do not spread.
Differences between NIH3T3 and other cell types have
been previously reported. In a recent review, Coleman
and Marshall discussed the discrepancies between
NIH3T3 and endothelial cells in Rac signaling for
cyclin D1 expression (Coleman and Marshall, 2001).
Among several proposals, they suggested: “NIH3T3
can have undergo genetics changes that liberate them
from Rac signaling”. Differences in sensitivity to Rac
signaling between the cells used in Carter’s study
and our VSMCs could explain our antagonistic
observations. In agreement with recent reports
proposing that some biological effects of ephrins are
due to a Rho-mediated increase of acto-myosin
contraction, we observed an enhancement of VSMC
spreading on ephrinA1/Fc by the ROCK inhibitor Y-
27632 (Lawrenson et al., 2002; Wahl et al., 2000).
However, repression of RhoA synthesis using an
siRNA strategy antagonizes this phenomenon only
partly, suggesting that RhoA has a limited role in this
cellular model. Nonetheless, the stabilization of
process formation in the absence of RhoA expression observed
in VSMCs and in HeLa cells (not shown) cultured on a
laminin+ephrinA1/Fc coat suggested that other biological
effects of ephrinA1, like outgrowth of neurites or regression of
melanoma cell processes, could be antagonized by an
inhibition of RhoA synthesis. Alternatively, Y-27632 could
also mediate its effect in our model through Rac, as it was
proposed that ROCK inhibition can enhance Rac activity (Hall
et al., 2001) and a recent study reported the activation of Rac
by Y27632 in VSMCs (Katsumi et al., 2002). Moreover, in
VSMCs cultured on laminin+ephrinA1/Fc, we observed that
Y-27632 induces a modest but reproducible increase of PAK1
phosphorylation level (C.D. and J.P., unpublished). By
contrast, it was also reported that Y-27632 did not exclusively
inhibit ROCK. At micromolar concentration, as it is commonly
used, Y-27632 can inhibit other kinases (Davies et al., 2000).
These side effects can also account for the partial reversion of
the ephrinA1-induced phenotype independently of its action on
the Rho pathway. Finally, the cooperativity between S1P and
ephrinA1/Fc reported here could represent a supplementary
control level of the ephrinA1 action in vivo, not only by
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Fig. 8. S1P amplifies the ephrinA1-mediated repression of VSMC spreading.
Representative phase-contrast microscopy of quiescent VSMCs cultured for 16
hours in the adhesion assay with vehicle (a-d) or with 0.5 m M S1P (e-h).
VSMCs where seeded on tissue culture dishes coated with laminin (0.25
m g/cm2) and either 1 m g/cm2 of Fc (a,e) or 0.2 (b,f), 0.5 (c,g), 1.0 (d,h) m g/cm2
of ephrinA1/Fc. Bar, 20 m m.
1375EphrinA1 inactivates integrins through rac
amplification of the effect but also by differential regulation on
endothelial and smooth muscle cells through opposite
regulation of RhoGTPases (Ryu et al., 2002).
In conclusion, our study underlines the implication of the
Rac/PAK pathway in ephrinA1-mediated integrin inactivation
in VSMCs whereas RhoA has a limited effect. These
mechanisms are potentially regulated by S1P, which could
participate in the early steps of angiogenesis. EphrinA1 can
operate through various proteins regulating the activity of
Rac1. Among them, GAPs like chimaerin and the
p190RhoGAP, or the recently identified GEF ephexin, are
potentially interesting candidates. Investigations are now in
progress to analyze the implications of some of these proteins
in our model.
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